Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

INO

Inovio Pharmaceuticals Inc

Dec 08 • 04:00PM ET

0.3800

Dollar change +0.0020
Percentage change 0.53	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.63	Insider Own	1.62%	Shs Outstand	272.99M	Perf Week	-4.52%
Market Cap	103.74M	Forward P/E	-	EPS next Y	-0.33	Insider Trans	0.00%	Shs Float	268.55M	Perf Month	0.00%
Income	-164.58M	PEG	-	EPS next Q	-0.11	Inst Own	20.48%	Short Float / Ratio	9.66% / 7.54	Perf Quarter	-17.03%
Sales	0.85M	P/S	122.04	EPS this Y	55.27%	Inst Trans	3.13%	Short Interest	25.95M	Perf Half Y	-27.31%
Book/sh	0.51	P/B	0.74	EPS next Y	36.31%	ROA	-56.26%	Target Price	0.40	Perf Year	-79.23%
Cash/sh	0.61	P/C	0.62	EPS next 5Y	41.50%	ROE	-81.30%	52W Range	0.32 - 1.99	Perf YTD	-75.64%
Dividend	-	P/FCF	-	EPS past 5Y	-1.47%	ROI	-110.19%	52W High	-80.90%	Beta	0.90
Dividend %	-	Quick Ratio	4.00	Sales past 5Y	73.62%	Gross Margin	-447.62%	52W Low	17.28%	ATR	0.03
Employees	184	Current Ratio	4.00	Sales Q/Q	-95.76%	Oper. Margin	-18966.53%	RSI (14)	44.28	Volatility	4.92% 7.30%
Optionable	Yes	Debt/Eq	0.22	EPS Q/Q	16.63%	Profit Margin	-19270.71%	Rel Volume	0.48	Prev Close	0.38
Shortable	Yes	LT Debt/Eq	0.08	Earnings	Nov 09 AMC	Payout	-	Avg Volume	3.44M	Price	0.38
Recom	3.00	SMA20	-3.30%	SMA50	-6.63%	SMA200	-36.67%	Volume	1,657,513	Change	0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-22	Downgrade	Maxim Group	Buy → Hold
Nov-01-22	Downgrade	BofA Securities	Neutral → Underperform	$2
Jul-19-22	Resumed	RBC Capital Mkts	Sector Perform	$5 → $4
May-11-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral	$8 → $10
Dec-29-21	Resumed	Jefferies	Hold	$8 → $6
Sep-10-21	Downgrade	BofA Securities	Neutral → Underperform	$9 → $8
Jun-24-21	Initiated	Jefferies	Hold	$9
Mar-23-21	Initiated	BofA Securities	Neutral	$13
Feb-12-21	Initiated	Oppenheimer	Outperform	$35
Nov-17-20	Downgrade	ROTH Capital	Neutral → Sell
Nov-10-20	Upgrade	ROTH Capital	Sell → Neutral	$8
Sep-28-20	Upgrade	Maxim Group	Hold → Buy	$20
Sep-28-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-01-20	Downgrade	ROTH Capital	Neutral → Sell	$11
Jul-01-20	Downgrade	Maxim Group	Buy → Hold
Jun-29-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-26-20	Downgrade	Stifel	Buy → Hold	$19 → $24
May-21-20	Initiated	The Benchmark Company	Buy	$28
Apr-30-20	Downgrade	ROTH Capital	Buy → Neutral	$13

Show Previous Ratings

Nov-14-23 10:56AM	The 3 Most Undervalued Biotech Stocks to Buy: November 2023 (InvestorPlace) +7.14%
Nov-10-23 03:38PM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:00AM	Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-09-23 04:42PM	Inovio: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
08:00AM	Loading…
Nov-01-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Oct-26-23 08:00AM	INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023 (PR Newswire)
Oct-19-23 09:53AM	Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why (Zacks)
Oct-10-23 08:00AM	INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program (PR Newswire) +41.00%
Sep-28-23 11:10AM	Inovio spinoff Geneos raises another $5M to advance therapeutic cancer vaccines (American City Business Journals)
Sep-27-23 07:39PM	Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million (PR Newswire)
Sep-07-23 08:00AM	INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-06-23 09:31PM	Philadelphia-area life sciences firms have now cut more than 500 jobs since the start of 2022 (American City Business Journals) -5.52%
Aug-29-23 08:00AM	INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire) +8.35%
Aug-09-23 08:30PM	Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript (Motley Fool)
05:40PM	Loading…
05:40PM	Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:38PM	Inovio: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update (PR Newswire)
Aug-04-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Jul-26-23 09:32AM	INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023 (PR Newswire)
Jun-23-23 04:10PM	INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions (GlobeNewswire)
Jun-01-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
May-25-23 08:00AM	INOVIO to Present at the 2023 Jefferies Healthcare Conference (PR Newswire)
May-23-23 04:13PM	INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission (PR Newswire)
May-15-23 12:00PM	All You Need to Know About Inovio (INO) Rating Upgrade to Buy (Zacks) +5.14%
06:08AM	These Analysts Think Inovio Pharmaceuticals, Inc.'s (NASDAQ:INO) Sales Are Under Threat (Simply Wall St.)
May-13-23 08:20AM	Analysts Have Lowered Expectations For Inovio Pharmaceuticals, Inc. (NASDAQ:INO) After Its Latest Results (Simply Wall St.)
May-12-23 06:14AM	Inovio Pharmaceuticals First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) -6.89%
May-11-23 03:30AM	Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript (Motley Fool)
May-10-23 05:45PM	Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
May-08-23 08:00AM	New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023 (PR Newswire)
May-05-23 08:00AM	INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference (PR Newswire)
Apr-28-23 08:00AM	INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 (PR Newswire)
Apr-27-23 08:00AM	INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis at COSM 2023 (PR Newswire)
Apr-26-23 08:00AM	European Committee for Orphan Medicinal Products Provides Positive Opinion on INOVIO's Application for Orphan Drug Designation for INO-3107 (PR Newswire)
Apr-17-23 01:55PM	These 3 Nasdaq Stocks Are on Fire Today: Here's Why (Motley Fool) +9.83%
08:00AM	Data from Phase 1b trial with INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) presented at ECCMID 2023 (PR Newswire)
Apr-13-23 02:07PM	Why Inovio Pharmaceuticals' Shares Jumped on Thursday (Motley Fool) +27.53%
Apr-12-23 08:00AM	INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) at ECCMID 2023 (PR Newswire)
Apr-04-23 03:10PM	Why Shares of Inovio Pharmaceuticals Were Down Tuesday (Motley Fool) -8.22%
Apr-03-23 08:00AM	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire)
Mar-06-23 01:07AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.33%
Mar-03-23 08:00AM	INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference (PR Newswire)
Mar-01-23 07:00PM	Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript (Motley Fool)
06:15PM	Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights (PR Newswire)
Feb-16-23 08:00AM	INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Feb-15-23 08:00AM	INOVIO to Report Fourth Quarter and Year-End 2022 Financial Results on March 1, 2023 (PR Newswire)
Feb-03-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire) +6.70%
Feb-02-23 01:39PM	Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola (Benzinga) +7.19%
08:00AM	INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) (PR Newswire)
Feb-01-23 01:55PM	3 Sorry Pharma Stocks to Sell in February Before Its Too Late (InvestorPlace)
Jan-31-23 11:40AM	Inovio Pharmaceuticals enacts its second round of layoffs in just over six months (American City Business Journals)
11:07AM	INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates (Benzinga)
08:00AM	INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine Candidates (PR Newswire)
Jan-03-23 07:27AM	Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69% (Simply Wall St.)
Nov-18-22 11:42AM	Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs (Benzinga) -8.97%
11:02AM	Inovio shares fall on discontinuation of development of two more vaccine candidates (American City Business Journals)
Nov-17-22 04:30PM	INOVIO Provides an Update on Lassa Fever and MERS Programs (PR Newswire)
09:23AM	3 Stocks to Avoid Right Now (Motley Fool)
Nov-08-22 10:00PM	Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript (Motley Fool)
06:25PM	Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:57PM	What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours (Benzinga)
04:05PM	INOVIO Reports Financial Results and Highlights for the Third Quarter 2022 (PR Newswire)
Oct-28-22 04:27PM	Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today (Motley Fool) +7.28%
12:37PM	Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster (Benzinga)
08:50AM	Inovio discontinues efforts to develop Covid-19 vaccine booster (American City Business Journals)
Oct-27-22 04:30PM	INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800 (PR Newswire)
Oct-26-22 10:41AM	Strength Seen in Immunocore Holdings PLC Sponsored ADR (IMCR): Can Its 10.2% Jump Turn into More Strength? (Zacks)
Oct-25-22 08:00AM	INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022 (PR Newswire) +9.30%
Oct-21-22 06:02PM	Inovio Pharmaceuticals, Inc. stock performance and analyst projections (Yahoo Finance Video) +7.93%
Oct-17-22 05:59PM	Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday (Motley Fool) +17.31%
Oct-13-22 10:30AM	Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease (Benzinga)
08:00AM	INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-25-22 09:05AM	Institutions along with individual investors who hold considerable shares inInovio Pharmaceuticals, Inc. (NASDAQ:INO) come under pressure; lose 11% of holdings value (Simply Wall St.)
Sep-11-22 10:53AM	1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals (Motley Fool)
Sep-07-22 10:12AM	Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate (Zacks)
Sep-01-22 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Aug-30-22 08:00AM	INOVIO to Present at the H.C. Wainwright 24th Annual Global Investment Conference (PR Newswire)
Aug-26-22 01:15PM	Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed (Benzinga) -8.22%
10:24AM	Inovio agrees to pay shareholders $44M in cash and stock to settle lawsuit tied to Covid vaccine candidate (American City Business Journals)
Aug-10-22 03:32PM	Why Inovio Pharmaceuticals Is Gaining Today (Motley Fool) +23.81%
12:01AM	Inovio Pharmaceuticals (INO) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 07:25PM	Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -11.02%
04:30PM	Edited Transcript of INO.OQ earnings conference call or presentation 9-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	INOVIO Reports Financial Results and Highlights for the Second Quarter 2022 (PR Newswire)
Aug-02-22 10:00AM	Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) +7.85%
Jul-27-22 08:25AM	Shareholders in Inovio Pharmaceuticals (NASDAQ:INO) are in the red if they invested a year ago (Simply Wall St.)
Jul-26-22 08:00AM	INOVIO to Report Second Quarter 2022 Financial Results on August 9, 2022 (PR Newswire)
Jul-25-22 09:42AM	WHO declares Monkeypox a global health emergency (Yahoo Finance Video) +5.24%
08:45AM	Vaccine Stocks Soar After the WHO Sounds the Alarm on Monkeypox (Barrons.com)
Jul-24-22 07:40AM	1 Beaten-Down Growth Stock To Avoid Like the Plague (Motley Fool)
Jul-22-22 06:30AM	After Slashing Costs, Is Inovio a Buy? (Motley Fool) -9.05%
Jul-20-22 06:14PM	Inovio is cutting its workforce by 18% as it moves to reduce expenses (American City Business Journals) +10.95%
Jul-19-22 03:14PM	RBC Capital Lowers Inovio Price Target As It Awaits This (Benzinga) +9.24%
11:35AM	Inovio Lays Out Corporate Reorganization To Extend Cash Runway Into 2024 (Benzinga)
08:29AM	UPDATE 1-Inovio to cut 18% full-time jobs to conserve cash (Reuters)
08:21AM	Inovio to reduce its workforce by 18% (MarketWatch)
08:00AM	INOVIO Announces Corporate Reorganization to Reduce Operational Expenses and Focus on Opportunities to Bring the Promise of DNA Medicines to Patients (PR Newswire)

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zoth Lota S.	Director	Jun 05	Sale	0.56	5,700	3,192	52,716	Jun 05 04:13 PM
Weiner David B.	Director	Mar 13	Sale	1.15	5,833	6,708	910,124	Mar 13 05:10 PM
Weiner David B.	Director	Feb 27	Sale	1.28	11,668	14,935	904,291	Feb 28 05:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INO

Inovio Pharmaceuticals Inc

Upgrade your FINVIZ experience